Biomaterial Database

Baricitinib in Alopecia Areata. 2022

Andrew Messenger, and Matthew Harries

From the Department of Infection, Immunity, and Cardiovascular Disease, University of Sheffield, Sheffield (A.M.), the Dermatology Centre, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford (M.H.), and the Centre for Dermatology Research, University of Manchester, Manchester Academic Health Science Centre and National Institute for Health Research Manchester Biomedical Research Centre, Manchester (M.H.) - all in the United Kingdom.

UI	MeSH Term	Description	Entries
D011687	Purines	A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D011720	Pyrazoles	Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075242	Janus Kinase Inhibitors	Agents that inhibit JANUS KINASES.	JAK Inhibitor,Janus Kinase Inhibitor,JAK Inhibitors,Inhibitor, JAK,Inhibitor, Janus Kinase,Inhibitors, JAK,Inhibitors, Janus Kinase,Kinase Inhibitor, Janus,Kinase Inhibitors, Janus
D000506	Alopecia Areata	Loss of scalp and body hair involving microscopically inflammatory patchy areas.	Alopecia Circumscripta
D001384	Azetidines
D013449	Sulfonamides	A group of compounds that contain the structure SO2NH2.	Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide